Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: Telehealth Pulmonary Rehabilitation for Hispanic and African-American Patients Admitted With Exacerbation of COPD [NA]
Clinical trial evaluating telehealth pulmonary rehabilitation for Hispanic and African-American patients hospitalized with COPD exacerbation…
-
FDA approval · 2022-03-02FDA Approved: ARFORMOTEROL TARTRATE INHALATION SOLUTION — Original Application (Ritedose Pharmaceuticals, LLC)
The FDA approved an original application for ARFORMOTEROL TARTRATE INHALATION SOLUTION (arformoterol tartrate inhalation solution) by Ritedo…
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Inhaled Amikacin in Preventing AECOPD [Phase 3]
A Phase 3 trial evaluating inhaled amikacin for preventing acute exacerbations in chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Portable Oxygen Concentrator Improvements to Physical Activity, Oxygen Usage, and Quality of Life in Chronic Obstructive Pulmonary Disease Patients Using Long-term Oxygen Therapy (POC-STEP) [NA]
A terminated clinical trial evaluating portable oxygen concentrator improvements on activity, oxygen usage, and quality of life in COPD pati…
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: Description of the Ability to Learn How to Handle Inhaler Devices in COPD [Phase 4]
A Phase 4 trial assessing the ability to learn how to handle inhaler devices in chronic obstructive pulmonary disease (COPD).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-02-10FDA Approved: ROFLUMILAST — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original ANDA for roflumilast by Zydus Pharmaceuticals USA Inc., enabling a generic version of this COPD therapy. This mark…
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults [Phase 2]
Phase 2 trial evaluating dehydroepiandrosterone (DHEA) for pulmonary hypertension in adults with chronic obstructive pulmonary disease (COPD…
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: INtervention Study In overweiGHT Patients With COPD [NA]
Clinical trial completed; results posted in 2022 for an intervention in overweight patients with COPD, but no specific results or efficacy d…
-
FDA approval · 2022-02-07FDA Approved: ARFORMOTEROL TARTRATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original ANDA for arformoterol tartrate, a generic long-acting beta-agonist bronchodilator for chronic o…
-
CLINICAL_TRIALS withdrawal · 2022-02-03Clinical Trial Update: TRIMBOW® and RELVAR® on Lung Stiffness Reduction Assessed Through Forced Oscillation Technique in Patients With COPD [Phase 4]
A Phase 4 trial assessing lung stiffness reduction with TRIMBOW and RELVAR in COPD has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2) [Phase 2]
A Phase 2 study evaluating safety and efficacy of SelK2 on airway responses after allergen challenge in asthma and COPD; study completed.
-
CLINICAL_TRIALS withdrawal · 2022-02-02Clinical Trial Update: Cycled Testosterone Administration During Pulmonary Rehabilitation in Early Stage COPD [Phase 2, Phase 3]
A clinical trial investigating cycled testosterone during pulmonary rehabilitation in early-stage COPD was withdrawn.
-
FDA approval · 2022-01-27FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
The FDA approved a supplemental application to market ProAir DigiHaler, a digital inhaler version of albuterol sulfate.
-
FDA approval · 2022-01-27FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Fluticasone Propionate and Salmeterol submitted by Teva Pharmaceuticals USA, Inc. The approval u…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Social Media-based Bundle Care of AECOPD Patients. [Phase 4]
A Phase 4 clinical trial update investigating a social media-based bundle care approach for patients with acute exacerbation of COPD, delive…
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease
Post-marketing surveillance study in Korean COPD patients evaluating Vahelva Respimat; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: The Effects of Enoximone in Acute Exacerbation COPD [Phase 4]
A Phase 4 trial evaluating enoximone in acute exacerbation of COPD has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-01-05Clinical Trial Update: De-implementing Inhaled Steroids to Improve Care and Safety in COPD [NA]
A completed clinical trial investigating the de-implementation of inhaled steroids to improve care and safety in chronic obstructive pulmona…
-
FDA approval · 2021-12-28FDA Approved: ALBUTEROL SULFATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for albuterol sulfate by Mylan Pharmaceuticals Inc., making this generic bronchodilator available. It …
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: The Natural History of Small Airways Physiology in Diseased and Healthy States
Clinical trial update on natural history of small airways physiology in diseased and healthy states; completed with results posted.
-
FDA approval · 2021-12-13FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic version of fluticasone propionate and salmeterol inhalation for the maintenance treatment of asthma and chronic …
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE] [Phase 4]
Phase 4 real-world trial comparing inhaled steroid-based triple therapy to tiotropium/olodaterol for reducing COPD exacerbations; results po…
-
CLINICAL_TRIALS research · 2021-12-03Clinical Trial Update: Monitoring and Peer Support to Improve Treatment Adherence and Outcomes [NA]
A completed clinical trial evaluating monitoring and peer support to improve treatment adherence and outcomes in chronic obstructive pulmona…
-
FDA approval · 2021-11-22FDA Approved: FORMOTEROL FUMARATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved an original application for a generic formoterol fumarate inhalation product by Alembic Pharmaceuticals Inc. The approval makes…
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Effect of BIBW 2948 BS in COPD [Phase 2]
Phase 2 trial results for BIBW 2948 BS in chronic obstructive pulmonary disease and chronic bronchitis have been completed with results post…